vb08pcld | Knowledge4COVID-19

Property	Value
?:creator	<https://research.tib.eu/covid-19/entity/Huang%2C_Edmund%3B_Jordan%2C_Stanley_C.>
?:doi	10.1056/nejme2032071
?:doi	<https://research.tib.eu/covid-19/entity/10.1056/nejme2032071>
?:journal	N_Engl_J_Med
?:license	no-cc
?:pdf_json_files	document_parses/pdf_json/3d079415100c7d460d933f5f227db8618a2f6ea3.json
?:pmc_json_files	document_parses/pmc_json/PMC7745168.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7745168>
?:pmid	<https://research.tib.eu/covid-19/entity/33296566.0>
?:pmid	33296566.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/vb08pcld_HAS_C1609165_TREATS_C5203670>
?:sha_id	<https://research.tib.eu/covid-19/entity/3d079415100c7d460d933f5f227db8618a2f6ea3>
?:source	Medline; PMC
?:title	Tocilizumab for Covid-19 — The Ongoing Search for Effective Therapies
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-12-10

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/vb08pcld>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/vb08pcld>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all